NL-OMON50801已完成不适用
Pancreatic cancer surveillance in CDKN2A and other high risk mutation carriers - PARSEC
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 280
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •In order to be eligible to participate in this study, a subject must be
- •participating in the LUMC PC surveillance program, which requires:
- •- aged between 40 and 75, and
- •i) a proven CDKN2A or LKB1/STK11 mutation, regardless of family history, or
- •ii) a BRCA1/2, PALB2, ATM, MLH1/MSH2/MSH6 mutation with at least one first
- •degree relative with PC.
排除标准
- •- Comorbidity leading to an impaired physical performance (World health
- •organization (WHO) performance status 3-4) or mental retardation.
- •- Life expectancy <5 years
- •- Very limited understanding of the Dutch or English language to be able to
- •make an informed choice.
- •- No informed consent.
研究者
相似试验
尚未招募
不适用
Pancreatic Cancer Surveillance in CDKN2A and Other High Risk Mutation CarriersPancreatic cancerNL-OMON27120eiden University Medical Center280
招募中
不适用
Koasato university Pancreatic cancer Screening Projectpancreatic cancerJPRN-UMIN000046880Kitasato University Hospital2,500
进行中（未招募）
不适用
K early detection initiative for pancreatic cancerPancreatic cancerCancerISRCTN12805385niversity of Liverpool2,500
已完成
不适用
Tumor profiling in pancreatic carcinoma, a multidisciplinary initiativepancreatic carcinoma10017990pancreatic cancerNL-OMON35953Academisch Medisch Centrum200
招募中
不适用
Project for detection of pancreatic cancer at an early stage with curative surgery in Osaka cityJPRN-UMIN000026915Tazuke Kofukai Medical Research Institute, Kitano Hospital400